A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

Research site 03, Dallas, Texas, United States

Research site 01, San Antonio, Texas, United States

Research site 02, Fairfax, Virginia, United States

Research site 05, Manchester, United Kingdom

Research site 04, Oxford, United Kingdom

Research site 06, Sutton, United Kingdom